Partnership to Develop Urea Cycle Disorders Therapy
Boehringer Ingelheim Partners with Thoeris to Investigate a Novel Approach to Treat Urea Cycle Disorders
Search
Meet the BD&L Team 2019
Hear from our team and find out more about our approach to partnering.
Supporting Rabies Free Pakistan Indus Hospital
Rabies endangers thousands of human lives in Pakistan every year. We provide green collars and vaccines to improve situation.
Isabel
In this video, Isabel shares how watching her children and grandchildren grow up inspires her to take the necessary steps to manage her life with type 2 diabetes and heart disease.
Phase II trials for patients with bronchiectasis
Bronchiectasis is a chronically progressive pulmonary disease. Boehringer Ingelheim investigates a potential new treatment option in two Phase II trials.
Life forward
In everything we do we can shape and influence the future for the better: Learn more about “Life forward” and how our innovations improve lives.
Update Israel and Gaza conflict
Update on Israel and the Palestine territories
Cancer's Big 4
We have a robust pipeline of clinical assets including cancer cell-directed therapies, for which we are investigating the key drivers of cancer such as P53 and KRAS.
Hannah Bussmann
Independent, authentic, bold - Hannah Bussmann’s career path
Ryan Henri Rickards
Independent, authentic, bold - Ryan Henri Rickards’ career path
Lung Repair & Regeneration Video
Lung repair & regeneration research addresses fundamental changes to lung architecture and how these changes impact lung function.
Veganism
Hear an expert’s opinion on the proposed link between a vegan diet and cancer recurrence rates.
FDA-Fast-Track-chronic-kidney-disease
FDA grants Fast Track designation for the treatment of chronic kidney disease, underscoring urgent need for new treatments for people living with the condition
Jessica Bürner
Independent, authentic, bold - Jessica Bürner’s career path
Biotherapeutics Modalities Infographic FINAL.pdf
Partnering in Biotherapeutics MAY 2024 CORP .pdf
Partnering in Biotherapeutics Technologies MARCH 2023 Corporate
Partnering in Biotherapeutics Technologies MARCH 2023 Corporate
Partnering in Biotherapeutics MAY 2023 Corp
Partnering in Biotherapeutics JUNE 2023 CORP
meat consumption market trends growth sustainability
In this article, we’re taking a look at global developments while highlighting one of the most important meat markets of the future: the Asian continent.
Martin Stefanic
Martin Stefanic, Patient Safety Therapeutic Area Head for Oncology, discusses his move to Patient Safety.
preventive care cat veterinarian
What can we all, cat owners or veterinarians, do to promote cat health? Click to find out!
Financial health
We constantly review our salaries to make sure they stay competitive in each market but we also provide wider support for financial health.
EMA filing acceptance and validation for spesolimab
The European Medicines Agency has accepted and validated the marketing authorization application for spesolimab in generalized pustular psoriasis